Status:
COMPLETED
Molecular Processes of the Relaxation Response in Older Adults
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
Stress
Eligibility:
All Genders
60-80 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to examine the molecular (nitric oxide) and biochemical (epinephrine, norepinephrine, cortisol and ACTH) parameters that are associated with RR elicitation and which may c...
Eligibility Criteria
Inclusion
- 60-80 years of age
- healthy individuals
- willing and able to attend treatment sessions
- willing to learn how to do and practice the relaxation-response
- access to a working telephone
- read and write English
Exclusion
- Major medical or psychiatric illness
- asthma or seasonal allergies (resulting in nitric oxide levels \>60 ppb)
- smoking
- previous relaxation-response practice
- current use of the following medications:systemic corticosteroids, anti-convulsants/psychotics, immunosuppressants, cytotoxic therapy, anabolic steroids, antidepressants (other than SSRIs), dicyclomine, bile acid binding resins, or sympathomimetic medication
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2007
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00179569
Start Date
August 1 2005
End Date
September 1 2007
Last Update
November 5 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BIDMC
Boston, Massachusetts, United States, 02215